Patents by Inventor Gabriel Baverel

Gabriel Baverel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for the non alcoholic steatohepatitis and fibrosis
    Patent number: 11324743
    Abstract: Compounds of formula (I) or their enantiomers, diastereoisomers thereof and the addition salts thereof with pharmaceutically acceptable bases or acids, for use for the prevention or treatment, preferably treatment, of NASH.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: May 10, 2022
    Assignee: METABOLYS
    Inventors: Gabriel Baverel, Gérard Moinet
  • NEW TREATMENT FOR THE NON ALCOHOLIC STEATOHEPATITIS AND FIBROSIS
    Publication number: 20190160057
    Abstract: Compounds of formula (I) or their enantiomers, diastereoisomers thereof and the addition salts thereof with pharmaceutically acceptable bases or acids, for use for the prevention or treatment, preferably treatment, of NASH.
    Type: Application
    Filed: August 3, 2017
    Publication date: May 30, 2019
    Inventors: Gabriel BAVEREL, Gérard MOINET
  • Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
    Patent number: 9545387
    Abstract: The present disclosure relates to a composition including, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), or the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I) is as follows: The present disclosure also relates to the use of this composition for the treatment of diseases associated with insulin resistance syndrome.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: January 17, 2017
    Assignee: METABOLYS
    Inventors: Gérard Moinet, Gabriel Baverel
  • Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
    Publication number: 20150297539
    Abstract: The present invention relates to a composition comprising, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I). The present invention also relates to the use of said composition for the treatment of diseases associated with insulin resistance syndrome.
    Type: Application
    Filed: December 17, 2013
    Publication date: October 22, 2015
    Applicant: METABOLYS
    Inventors: Gérard MOINET, Gabriel BAVEREL
  • Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
    Patent number: 9150529
    Abstract: The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: October 6, 2015
    Assignee: METABOLYS
    Inventors: Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
  • Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
    Patent number: 9150523
    Abstract: Disclosed herein are compounds and compositions useful in the treatment of pathologies associated with the insulin resistance syndrome (or syndrome X), in particular in the treatment of type 2 diabetes.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: October 6, 2015
    Assignee: METABOLYS
    Inventors: Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
  • PIPERAZINE DERIVATIVES, METHODS FOR PREPARING SAME, AND USES THEREOF IN THE TREATMENT OF INSULIN RESISTANCE
    Publication number: 20140235650
    Abstract: The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
    Type: Application
    Filed: June 22, 2012
    Publication date: August 21, 2014
    Applicant: Metabolys
    Inventors: Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
  • PIPERAZINE DERIVATIVES, METHODS FOR PREPARING SAME, AND USES THEREOF IN THE TREATMENT OF INSULIN RESISTANCE
    Publication number: 20140155409
    Abstract: The invention relates to a compound of formula (I), where R1, R2, R3, m, n, and L1 are as defined in claim 1, to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
    Type: Application
    Filed: June 22, 2012
    Publication date: June 5, 2014
    Applicant: Metabolys
    Inventors: Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier